亚宝药业（广东横琴）有限公司成立

Group 1 - The core point of the article is the establishment of a new company, 亚宝药业（600351）(广东横琴)有限公司, with a registered capital of 100 million yuan, focusing on medical research and development, biochemistry product technology research, and bio-based material polymer technology research [1] Group 2 - The new company is jointly owned by 亚宝药业 and 亚宝药业(澳门)有限公司, indicating a strategic partnership in the development of innovative healthcare solutions [1]